Snail-regulated MiR-375 inhibits migration and invasion of gastric cancer cells by targeting JAK2

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Xu, Yanjun ^a,b   Jin, Juan ^b   Liu, Yiman ^b   Huang, Zhenxia ^b   Deng, Yujie ^b   You, Tao ^c   Zhou, Tianhua ^b,d   Si, Jianmin ^d,e   Zhuo, Wei ^b,d  

^a ZHEJIANG CANCER HOSPITAL   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

^e ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2; MICRORNA 375; TRANSCRIPTION FACTOR SLUG; MICRORNA; MIRN375 MICRORNA, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC REGULATION; HUMAN; HUMAN TISSUE; METASTASIS POTENTIAL; MIGRATION INHIBITION; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; STOMACH CANCER; TUMOR INVASION; CELL MOTION; DOWN REGULATION; GENETICS; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; WOUND HEALING;

CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JANUS KINASE 2; MICRORNAS; NEOPLASM INVASIVENESS; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; WOUND HEALING;

EID: 84904682519     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099516     Document Type: Article

References (35)

1. Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 1: 571-573.
2. Fidler IJ (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458.
3. Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895-904.
4. Oue N, Aung PP, Mitani Y, Kuniyasu H, Nakayama H, et al. (2005) Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression. Oncology 69 Suppl 1: 17-22. (Pubitemid 41433537)
5. Klein CA (2008) Cancer. The metastasis cascade. Science 321: 1785-1787.
6. Zhao X, Dou W, He L, Liang S, Tie J, et al. (2013) MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene 32: 1363-1372.
7. Huang X, Zou Y, Lian L, Wu X, He X, et al. (2013) Changes of T Cells and Cytokines TGF-beta1 and IL-10 in Mice During Liver Metastasis of Colon Carcinoma: Implications for Liver Anti-tumor Immunity. J Gastrointest Surg.
8. Reticker-Flynn NE, Malta DF, Winslow MM, Lamar JM, Xu MJ, et al. (2012) A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nat Commun 3: 1122.
9. Savita U, Karunagaran D (2013) MicroRNA-106b-25 cluster targets beta-TRCP2, increases the expression of Snail and enhances cell migration and invasion in H1299 (non small cell lung cancer) cells. Biochem Biophys Res Commun 434: 841-847.
10. Zhong J, Ogura K, Wang Z, Inuzuka H (2013) Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis. Discov Med 15: 7-15.
11. Teng Y, Mei Y, Hawthorn L, Cowell JK (2013) WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells. Oncogene. [Epub ahead of print]
12. Ambros V (2001) microRNAs: tiny regulators with great potential. Cell 107: 823-826.
13. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M (2012) microRNAs in cancer management. Lancet Oncol 13: e249-258.
14. Zhou L, Yang ZX, Song WJ, Li QJ, Yang F, et al. (2013) MicroRNA-21 regulates the migration and invasion of a stem-like population in hepatocellular carcinoma. Int J Oncol.
15. Li J, Song Y, Wang Y, Luo J, Yu W (2013) MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells. Mol Cell Biochem.
16. Profumo V, Gandellini P (2013) MicroRNAs: cobblestones on the road to cancer metastasis. Crit Rev Oncog 18: 341-355.
17. Yao Q, Cao Z, Tu C, Zhao Y, Liu H, et al. (2013) MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2. Cancer Lett 335: 219-224.
18. Zheng L, Qi T, Yang D, Qi M, Li D, et al. (2013) microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1. PLoS One 8: e55719.
19. Tie J, Pan Y, Zhao L, Wu K, Liu J, et al. (2010) MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 6: e1000879.
20. Ding L, Xu Y, Zhang W, Deng Y, Si M, et al. (2010) MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res 20: 784-793.
21. Avnit-Sagi T, Kantorovich L, Kredo-Russo S, Hornstein E, Walker MD (2009) The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas. PLoS One 4: e5033.
22. Xu Y, Zhao F, Wang Z, Song Y, Luo Y, et al. (2012) MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene 31: 1398-1407.
23. Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, et al. (2010) MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 70: 2339-2349.
24. Harpur AG, Andres AC, Ziemiecki A, Aston RR, Wilks AF (1992) JAK2, a third member of the JAK family of protein tyrosine kinases. Oncogene 7: 1347-1353.
25. Levine RL, Pardanani A, Tefferi A, Gilliland DG (2007) Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer 7: 673-683. (Pubitemid 47327415)
26. Hedvat M, Huszar D, Herrmann A, Gozgit JM, Schroeder A, et al. (2009) The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors. Cancer Cell 16: 487-497.
27. Gäbler K, Behrmann I, Haan C (2013) JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms. JAKSTAT 2:e25025.
28. Hemavathy K, Ashraf SI, Ip YT (2000) Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Gene 257: 1-12.
29. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83.
30. He H, Chen W, Wang X, Wang C, Liu F, et al. (2012) Snail is an independent prognostic predictor for progression and patient survival of gastric cancer. Cancer Sci.
31. Woo HY, Min AL, Choi JY, Bae SH, Yoon SK, et al. (2011) Clinicopathologic significance of the expression of Snail in hepatocellular carcinoma. Korean J Hepatol 17: 12-18.
32. Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, et al. (2002) Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 21: 3241-3246. (Pubitemid 34548095)
33. Fan XJ, Wan XB, Yang ZL, Fu XH, Huang Y, et al. (2013) Snail promotes lymph node metastasis and Twist enhances tumor deposit formation through epithelial-mesenchymal transition in colorectal cancer. Hum Pathol 44: 173-180.
34. Cai J. (2013) Roles of transcriptional factor Snail and adhesion factor E-cadherin in clear cell renal cell carcinoma. Exp Ther Med. 6: 1489-1493.
35. Muenst S, Däster S, Obermann EC, Droeser RA, Weber WP, et al. (2013) Nuclear expression of snail is an independent negative prognostic factor in human breast cancer. Dis Markers. 35: 337-44.